Market Closed -
Bombay S.E.
11:00:56 26/06/2024 BST
|
5-day change
|
1st Jan Change
|
5.48
INR
|
+0.92%
|
|
-1.97%
|
+11.84%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
216.8
|
156.7
|
89.33
|
124.9
|
203.7
|
187.6
|
Enterprise Value (EV)
1 |
1,436
|
1,406
|
1,260
|
1,213
|
1,246
|
1,281
|
P/E ratio
|
-2.81
x
|
-0.67
x
|
-1.44
x
|
-3
x
|
20.5
x
|
-661
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.63
x
|
0.63
x
|
2.71
x
|
11.4
x
|
5.36
x
|
7.87
x
|
EV / Revenue
|
4.16
x
|
5.65
x
|
38.2
x
|
111
x
|
32.8
x
|
53.8
x
|
EV / EBITDA
|
117
x
|
-33.1
x
|
-61.2
x
|
-52.4
x
|
52.9
x
|
-52.8
x
|
EV / FCF
|
-45.4
x
|
17
x
|
19.4
x
|
22.4
x
|
31.7
x
|
46.9
x
|
FCF Yield
|
-2.2%
|
5.9%
|
5.17%
|
4.46%
|
3.15%
|
2.13%
|
Price to Book
|
2.45
x
|
-0.41
x
|
-0.17
x
|
-0.23
x
|
-0.38
x
|
-0.24
x
|
Nbr of stocks (in thousands)
|
52,242
|
52,242
|
52,242
|
52,242
|
52,242
|
52,242
|
Reference price
2 |
4.150
|
3.000
|
1.710
|
2.390
|
3.900
|
3.590
|
Announcement Date
|
05/09/18
|
05/09/19
|
01/09/20
|
31/08/21
|
06/09/22
|
06/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
345
|
248.8
|
32.99
|
10.92
|
38.03
|
23.82
|
EBITDA
1 |
12.24
|
-42.51
|
-20.57
|
-23.18
|
23.54
|
-24.28
|
EBIT
1 |
-36.63
|
-91.5
|
-54.48
|
-57
|
-10.17
|
-72.9
|
Operating Margin
|
-10.62%
|
-36.78%
|
-165.12%
|
-521.91%
|
-26.74%
|
-306.01%
|
Earnings before Tax (EBT)
1 |
-77.07
|
-185.8
|
-62.02
|
-42.64
|
27.33
|
-331.5
|
Net income
1 |
-77.07
|
-235.3
|
-62.02
|
-41.57
|
10.1
|
-0.054
|
Net margin
|
-22.34%
|
-94.57%
|
-187.96%
|
-380.63%
|
26.56%
|
-0.23%
|
EPS
2 |
-1.475
|
-4.503
|
-1.187
|
-0.7957
|
0.1903
|
-0.005430
|
Free Cash Flow
1 |
-31.66
|
82.94
|
65.08
|
54.17
|
39.3
|
27.31
|
FCF margin
|
-9.18%
|
33.34%
|
197.25%
|
495.99%
|
103.33%
|
114.64%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
166.89%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
388.98%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
05/09/18
|
05/09/19
|
01/09/20
|
31/08/21
|
06/09/22
|
06/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,219
|
1,249
|
1,170
|
1,088
|
1,042
|
1,093
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
99.62
x
|
-29.38
x
|
-56.89
x
|
-46.96
x
|
44.26
x
|
-45.04
x
|
Free Cash Flow
1 |
-31.7
|
82.9
|
65.1
|
54.2
|
39.3
|
27.3
|
ROE (net income / shareholders' equity)
|
-50.5%
|
159%
|
13.7%
|
8.07%
|
-5.09%
|
50%
|
ROA (Net income/ Total Assets)
|
-1.62%
|
-5.02%
|
-3.84%
|
-4.26%
|
-0.78%
|
-6.17%
|
Assets
1 |
4,770
|
4,684
|
1,615
|
975.6
|
-1,302
|
0.8747
|
Book Value Per Share
2 |
1.690
|
-7.340
|
-10.00
|
-10.20
|
-10.30
|
-15.00
|
Cash Flow per Share
2 |
0.0300
|
0.0200
|
0.0100
|
0.6700
|
0.0400
|
0.0300
|
Capex
1 |
3.71
|
3.85
|
-
|
-
|
-
|
-
|
Capex / Sales
|
1.08%
|
1.55%
|
-
|
-
|
-
|
-
|
Announcement Date
|
05/09/18
|
05/09/19
|
01/09/20
|
31/08/21
|
06/09/22
|
06/09/23
|
|
1st Jan change
|
Capi.
|
---|
| +11.84% | 3.4M | | +2.87% | 103B | | -11.86% | 59.25B | | +68.10% | 47.15B | | +11.66% | 37.09B | | +0.42% | 31.09B | | +4.59% | 18.82B | | +14.08% | 16.97B | | +7.06% | 13.67B | | -8.41% | 12.77B |
Other Commodity Chemicals
|